Search hospitals

>

California

>

San Francisco

Veterans Affairs Medical Center - San Francisco

Claim this profile

San Francisco, California 94121

Global Leader in Post-Traumatic Stress Disorder

Global Leader in Lung Cancer

Conducts research for Prostate Cancer

Conducts research for HIV Infection

Conducts research for Human Immunodeficiency Virus Infection

326 reported clinical trials

32 medical researchers

Photo of Veterans Affairs Medical Center - San Francisco in San FranciscoPhoto of Veterans Affairs Medical Center - San Francisco in San FranciscoPhoto of Veterans Affairs Medical Center - San Francisco in San Francisco

Summary

Veterans Affairs Medical Center - San Francisco is a medical facility located in San Francisco, California. This center is recognized for care of Post-Traumatic Stress Disorder, Lung Cancer, Prostate Cancer, HIV Infection, Human Immunodeficiency Virus Infection and other specialties. Veterans Affairs Medical Center - San Francisco is involved with conducting 326 clinical trials across 363 conditions. There are 32 research doctors associated with this hospital, such as Sunny Wang, Warren J Gasper, MD, Ellen Herbst, MD, and Elaine Tseng, MD, FACS.

Area of expertise

1

Post-Traumatic Stress Disorder

Global Leader

Veterans Affairs Medical Center - San Francisco has run 31 trials for Post-Traumatic Stress Disorder.

2

Lung Cancer

Global Leader

Veterans Affairs Medical Center - San Francisco has run 27 trials for Lung Cancer. Some of their research focus areas include:

Stage II
Stage IV
Stage I

Top PIs

Clinical Trials running at Veterans Affairs Medical Center - San Francisco

Lung Cancer

Prostate Cancer

Post-Traumatic Stress Disorder

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Parkinson's Disease

Cardiovascular Disease

Insomnia

Cancer

Depression

Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Image of trial facility.

Guardant Health ct-DNA Assay

for Lung Cancer

This is a prospective observational study that will follow patients who undergo lung cancer screening at the San Francisco VA Medical Center, University of California, San Francisco (UCSF) Medical Center, and the San Francisco General Hospital. The proposed study will comprise of two primary populations to determine the ctDNA assay performance in a variety of clinical settings.

Recruiting

1 award

N/A

4 criteria

Image of trial facility.

Supportive Care Models

for Cancer

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Recruiting

1 award

N/A

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Veterans Affairs Medical Center - San Francisco?

Where is Veterans Affairs Medical Center - San Francisco located?

Who should I call to ask about financial aid or insurance network?

What insurance does Veterans Affairs Medical Center - San Francisco accept?

What awards or recognition has Veterans Affairs Medical Center - San Francisco received?